help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 1, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-1375
A more recent version of this article appeared on June 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/6/3279    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Aken, M. O.
Right arrow Articles by Romijn, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Aken, M. O.
Right arrow Articles by Romijn, J. A.

Submitted on July 15, 2004
Accepted on February 22, 2005

Quality of Life in Patients After Long-term Biochemical Cure of Cushing's Disease

M. O. van Aken, A. M Pereira, N. R. Biermasz, S. W. van Thiel, H. C. Hoftijzer, J. W.A. Smit, F. Roelfsema, S. W.J. Lamberts, and J. A. Romijn*

Departments of Endocrinology, Leiden University Medical Center, Leiden, and Erasmus Medical Center, Rotterdam, The Netherlands

* To whom correspondence should be addressed. E-mail: j.a.romijn{at}lumc.nl.

To evaluate the long-term impact of cured Cushing's disease on subjective well being, we assessed quality of life by validated health-related questionnaires in 58 patients cured from Cushing's disease by transsphenoidal surgery (n = 58), some of whom received additional radiotherapy (n = 11) and/or bilateral adrenalectomy (n = 3). The mean duration of remission was 13.4 ± 6.7 yr (range 2 - 25 yr). Patient data were compared with a control group of 98 healthy subjects with the same age and sex distribution, and with age-adjusted reference values available from the literature.

General perceived well being, measured by the Nottingham Health Profile (NHP) and the Short Form (SF-36), was reduced compared with controls for all subscales (P < 0.001). Patients with Cushing's disease had worse scores on subscales of fatigue (Multidimensional Fatigue Index: MFI-20), anxiety and depression (Hospital Anxiety and Depression Scale). Compared with reference values from the literature, quality of life was also reduced in the patients according to all questionnaires and all items, except pain (SF-36), sleep (NHP) and reduced activity (MFI-20). Despite conventional hormone replacement therapy, hypopituitarism was an important independent predictor of reduced quality of life. Patients without hypopituitarism (n = 28) showed reduced scores on physical items, but normal scores on mental items compared with controls.

In conclusion, despite long term cure of Cushing's disease, patients experience a considerable decrease in quality of life, with physical and psychosocial impairments, especially in the presence of hypopituitarism.


Key words: Cushing's disease • hypercortisolism • quality of life




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
S M Webb, X Badia, M J Barahona, A Colao, C J Strasburger, A Tabarin, M O van Aken, R Pivonello, G Stalla, S W J Lamberts, et al.
Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire
Eur. J. Endocrinol., May 1, 2008; 158(5): 623 - 630.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B Havekes, A A van der Klaauw, H C Hoftijzer, J C Jansen, A G L van der Mey, A H J T Vriends, J W A Smit, J A Romijn, and E P M Corssmit
Reduced quality of life in patients with head-and-neck paragangliomas
Eur. J. Endocrinol., February 1, 2008; 158(2): 247 - 253.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. C. Hoftijzer, K. A. Heemstra, E. P. M. Corssmit, A. A. van der Klaauw, J. A. Romijn, and J. W. A. Smit
Quality of Life in Cured Patients with Differentiated Thyroid Carcinoma
J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 200 - 203.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Hahner, M. Loeffler, M. Fassnacht, D. Weismann, A.-C. Koschker, M. Quinkler, O. Decker, W. Arlt, and B. Allolio
Impaired Subjective Health Status in 256 Patients with Adrenal Insufficiency on Standard Therapy Based on Cross-Sectional Analysis
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3912 - 3922.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M Kars, A A van der Klaauw, C S Onstein, A M Pereira, and J A Romijn
Quality of life is decreased in female patients treated for microprolactinoma
Eur. J. Endocrinol., August 1, 2007; 157(2): 133 - 139.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
F. Pecori Giraldi, M. Andrioli, L. De Marinis, A. Bianchi, A. Giampietro, M. De Martin, E. Sacco, M. Scacchi, A. Pontecorvi, and F. Cavagnini
Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease
Eur. J. Endocrinol., February 1, 2007; 156(2): 233 - 239.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. M. Dekkers, A. A. van der Klaauw, A. M. Pereira, N. R. Biermasz, P. J. Honkoop, F. Roelfsema, J. W. A. Smit, and J. A. Romijn
Quality of Life Is Decreased after Treatment for Nonfunctioning Pituitary Macroadenoma
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3364 - 3369.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. M. Dekkers, A. M. Pereira, F. Roelfsema, J. H. C. Voormolen, K. J. Neelis, M. A. Schroijen, J. W. A. Smit, and J. A. Romijn
Observation Alone after Transsphenoidal Surgery for Nonfunctioning Pituitary Macroadenoma
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1796 - 1801.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
O M Dekkers, N R Biermasz, J W A Smit, L E Groot, F Roelfsema, J A Romijn, and A M Pereira
Quality of life in treated adult craniopharyngioma patients.
Eur. J. Endocrinol., March 1, 2006; 154(3): 483 - 489.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. R. Lindsay, T. Nansel, S. Baid, J. Gumowski, and L. K. Nieman
Long-Term Impaired Quality of Life in Cushing's Syndrome despite Initial Improvement after Surgical Remission
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 447 - 453.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society